Literature DB >> 16092938

Chronic hyperammonemia in vivo impairs long-term potentiation in hippocampus by altering activation of cyclic GMP-dependent-protein kinase and of phosphodiesterase 5.

Pilar Monfort1, María-Dolores Muñoz, Vicente Felipo.   

Abstract

Long-term potentiation (LTP) is impaired in the CA1 area of hippocampal slices from rats with chronic moderate hyperammonemia. We studied the mechanisms by which hyperammonemia in vivo impairs LTP. This process requires sequential activation of soluble guanylate cyclase, cyclic GMP-dependent protein kinase (PKG) and cyclic GMP-degrading phosphodiesterase. Application of the tetanus induced a rapid increase of cyclic GMP in slices from control or hyperammonemic rats, which is followed in control slices by a sustained decrease in cyclic GMP due to sustained activation of cyclic GMP-degrading phosphodiesterase, which in turn is due to sustained activation of PKG. In slices from rats with chronic hyperammonemia tetanus-induced decrease in cyclic GMP was delayed and transient due to lower and transient activation of PKG and of the phosphodiesterase. Hyperammonemia-induced impairment of LTP may be involved in the alterations of cognitive function in patients with hepatic encephalopathy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16092938     DOI: 10.1111/j.1471-4159.2005.03236.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  10 in total

1.  Cyclic GMP in blood and minimal hepatic encephalopathy: fine-tuning of the diagnosis.

Authors:  Jan Albrecht
Journal:  J Mol Med (Berl)       Date:  2007-02-02       Impact factor: 4.599

2.  Characterization of the CA1 pyramidal neurons in rat model of hepatic cirrhosis: insights into their electrophysiological properties.

Authors:  Mahshid Tahamtan; Iraj Aghaei; Vahid Pooladvand; Vahid Sheibani; Mohammad Khaksari; Mohammad Shabani
Journal:  Metab Brain Dis       Date:  2017-03-07       Impact factor: 3.584

Review 3.  Cyclic GMP pathways in hepatic encephalopathy. Neurological and therapeutic implications.

Authors:  Carmina Montoliu; Regina Rodrigo; Pilar Monfort; Marta Llansola; Omar Cauli; Jordi Boix; Nisrin Elmlili; Ana Agusti; Vicente Felipo
Journal:  Metab Brain Dis       Date:  2010-03-02       Impact factor: 3.584

4.  Peroxisome proliferator-activated receptor-γ doesn't modify altered electrophysiological properties of the CA1 pyramidal neurons in a rat model of hepatic cirrhosis.

Authors:  Mahshid Tahamtan; Iraj Aghaei; Mohammad Shabani; Abbas Nazari; Vahid Pooladvand; Moazamehosadat Razavinasab
Journal:  Metab Brain Dis       Date:  2022-08-09       Impact factor: 3.655

5.  Metabolites Alterations and Liver Injury in Hepatic Encephalopathy Models Evaluated by Use of 7T-MRI.

Authors:  Shigeyoshi Saito; Narumi Arihara; Reika Sawaya; Daisuke Morimoto-Ishikawa; Junpei Ueda
Journal:  Metabolites       Date:  2022-04-27

6.  Impaired novelty acquisition and synaptic plasticity in congenital hyperammonemia caused by hepatic glutamine synthetase deficiency.

Authors:  Aisa N Chepkova; Olga A Sergeeva; Boris Görg; Helmut L Haas; Nikolaj Klöcker; Dieter Häussinger
Journal:  Sci Rep       Date:  2017-01-09       Impact factor: 4.379

7.  Hyperammonemia alters membrane expression of GluA1 and GluA2 subunits of AMPA receptors in hippocampus by enhancing activation of the IL-1 receptor: underlying mechanisms.

Authors:  Lucas Taoro-Gonzalez; Yaiza M Arenas; Andrea Cabrera-Pastor; Vicente Felipo
Journal:  J Neuroinflammation       Date:  2018-02-08       Impact factor: 8.322

Review 8.  Disturbance of the Glutamate-Glutamine Cycle, Secondary to Hepatic Damage, Compromises Memory Function.

Authors:  Ilhuicamina Daniel Limón; Isael Angulo-Cruz; Lesli Sánchez-Abdon; Aleidy Patricio-Martínez
Journal:  Front Neurosci       Date:  2021-01-27       Impact factor: 4.677

Review 9.  The Association between Hepatic Encephalopathy and Diabetic Encephalopathy: The Brain-Liver Axis.

Authors:  So Yeong Cheon; Juhyun Song
Journal:  Int J Mol Sci       Date:  2021-01-05       Impact factor: 5.923

10.  Thymoquinone improves cognitive and hippocampal long-term potentiation deficits due to hepatic encephalopathy in rats.

Authors:  Somayeh Hajipour; Yaghoob Farbood; Mahin Dianat; Mohammad Rashno; Laya Sadat Khorsandi; Alireza Sarkaki
Journal:  Iran J Basic Med Sci       Date:  2021-07       Impact factor: 2.699

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.